Women have better long-term prognosis than men after cardiac resynchronization therapy

Europace

Volumn 14, Issue 8, 2012, Pages 1148-1155

  Zabarovskaja, Stanislava ^a,b   Gadler, Fredrik ^a,b   Braunschweig, Frieder ^a,b   Ståhlberg, Marcus ^a,b   Hörnsten, Jonas ^a,b   Linde, Cecilia ^a,b   Lund, Lars H ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiac resynchronization therapy; Gender; Heart failure; Long term prognosis; Outcome

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BLEEDING; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; DEFIBRILLATOR; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HUMAN; INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERFORATION; PNEUMOTHORAX; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84864420053     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus039     Document Type: Article

References (36)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
3. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80. (Pubitemid 32224395)
4. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. (Pubitemid 34603028)
5. St John Sutton M, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation 2009;120:1858-65.
6. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
7. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95.
8. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009;54:1837-46.
9. Lund LH, Mancini D. Heart failure in women. Med Clin North Am 2004;88: 1321-45, xii.
10. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol 2005;12:107-13. (Pubitemid 40386293)
11. Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol 2011;57:813-20.
12. Linde C, Braunschweig F, Gadler F, Bailleul C, Daubert JC. Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC). Am J Cardiol 2003;91:1090-5. (Pubitemid 36514925)
13. Auricchio A, Metra M, Gasparini M, Lamp B, Klersy C, Curnis A et al. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. Am J Cardiol 2007;99:232-8. (Pubitemid 46084859)
14. van Bommel RJ, Borleffs CJ, Ypenburg C, Marsan NA, Delgado V, Bertini M et al. Morbidity and mortality in heart failure patients treated with cardiac resynchro-nization therapy: influence of pre-implantation characteristics on long-term outcome. Eur Heart J 2010;31:2783-90.
15. Kronborg MB, Mortensen PT, Kirkfeldt RE, Nielsen JC. Very long term follow-up of cardiac resynchronization therapy: clinical outcome and predictors of mortality. Eur J Heart Fail 2008;10:796-801.
16. Yarnoz MJ, Curtis AB. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use. Cardiol Rev 2006;14:292-8. (Pubitemid 44624588)
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70. (Pubitemid 29135798)
18. Brignole M, Gammage M, Puggioni E, Alboni P, Raviele A, Sutton R et al. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. Eur Heart Jo 2005;26:712-22. (Pubitemid 40516884)
19. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-72. (Pubitemid 46018278)
20. Taneja T, Mahnert BW, Passman R, Goldberger J, Kadish A. Effects of sex and age on electrocardiographic and cardiac electrophysiological properties in adults. Pacing Clin Electrophysiol 2001;24:16-21. (Pubitemid 32165723)
21. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987;75:565-72. (Pubitemid 17026046)
22. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-60.
23. Gasparini M, Lunati M, Santini M, Tritto M, Curnis A, Bocchiardo M et al. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry. Pacing Clin Electrophysiol 2006;29(Suppl. 2):S2-10.
24. Fazio S, Biondi B, Sabatini D, Cuocolo A, Tommaselli AP, Lombardi G et al. Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy. J Clin Endocrinol Metab 1996;81: 887-90.
25. Hsich EM, Pina IL. Heart failure in women: a need for prospective data. J Am Coll Cardiol 2009;54:491-8.
26. Mezu U, Bott-Silverman C, Hsich E. Heart failure in women is different than in men; should treatment be different? Cleve Clin J Med 2007;74:423-4, 6, 9-35.
27. Lenzen MJ, Rosengren A, Scholte op Reimer WJ, Follath F, Boersma E, Simoons ML et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart 2008;94:e10.
28. Sueta CA, Bertoni AG, Massing MW, McArdle J, Duren-Winfield V, Davis J et al. Managed care patients with heart failure: spectrum of ventricular dysfunction and predictors of medication utilization. J Card Fail 2005;11:106-11. (Pubitemid 40269784)
29. Stromberg A, Martensson J. Gender differences in patients with heart failure. Eur J Cardiovasc Nurs 2003;2:7-18. (Pubitemid 36842691)
30. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009;119:1078-84.
31. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86. (Pubitemid 30419053)
32. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342:1887-92. (Pubitemid 30419054)
33. McAlister FA, Tu JV, Newman A, Lee DS, Kimber S, Cujec B et al. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J 2006;27:323-9. (Pubitemid 43100028)
34. Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M et al. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 2009;11:480-8.
35. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase. Eur Heart J 2006;27:1928-32. (Pubitemid 44297365)
36. Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Eur Heart J 2011; 32:1631-1639.